Key facts
| Price (PPV) | 54 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | ramipril |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09AA05 |
| Manufacturer | MAPHAR |
| Presentation | Boîte de 30 |
| Nature | Médicament |
| Hospital price | 33.70 MAD |
| Data collected on | 9/8/2026 |
Indications
Hypertension. Prophylaxie à long terme après un infarctus du myocarde chez les patients souffrant d'une insuffisance cardiaque cliniquement manifeste. Traitement de l'insuffisance cardiaque symptomatique pour soutenir un traitement diurétique avec ou sans glucoside cardiotonique. Diminution du risque d'infarctus du myocarde, d'accident vasculaire cérébral ou de décès d'origine cardio-vasculaire chez les patients ayant un risque cardio-vasculaire élevé et/ou un diabète de type 2. Néphropathie glomérulaire avec protéinurie supérieure à 3 g/jour.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
In Morocco, 3 other products contain the same active substance as Ramipril Win 5 mg (Ramipril), at the same strength and in the same dosage form. For the same pack size (Boîte de 30), the cheapest is Priril 5 mg (PHARMA5) at 47.60 MAD, i.e. 12 % less than Ramipril Win 5 mg (54 MAD). The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Priril 5 mg | PHARMA5 | Boite de 30 | 47.60 MAD | 1.59 / unit | −12 % |
| Genpress 5 mg | GENPHARMA | Boîte de 30 | 63 MAD | 2.10 / unit | — |
| Triatec 5 mg | SANOFI AVENTIS MAROC | Boîte de 30 | 122.10 MAD | 4.07 / unit | — |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Ramipril Win 5 mg
Ramipril Win 5 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by MAPHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Ramipril Win 5 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Ramipril Win 5 mg
Answers to common questions from Moroccan patients about this drug.